News & Events

QbD Group and delaware strengthen partnership to accelerate digitalization in life sciences

QbD Group — Thu, 27 Nov 2025 09:00:00 GMT

The partnership is part of QbD Group’s broader Digitalization Services offering, supporting companies across the full software lifecycle—from process digitalization and IT infrastructure qualification to operational software compliance.

QbD Group Joins ASEBIO: A strategic Step in Our Commitment to Scientific Excellence

QbD Group — Wed, 12 Nov 2025 15:35:31 GMT

At QbD Group, we are proud to announce that this year we have become proud members of ASEBIO. This alliance reinforces our commitment to quality, regulatory compliance, and patient safety, the three pillars that underpin our mission within the life sciences sector.

In this interview with ASEBIO, Almudena del Castillo, Country Manager Spain at QbD Group, shares our perspective on how specialized quality and compliance consulting can contribute to strengthening the Spanish biotech ecosystem. She also discusses current regulatory challenges, innovation across the industry, and the value of collaborating closely with other key stakeholders in the field.

QbD Group recognized as Best Pharmacovigilance Service Company at Farmaforum 2025

QbD Group — Thu, 18 Sep 2025 22:00:00 GMT

QbD Group welcomes Dr. Diane Fairweather as Division Head Clinical

QbD Group — Tue, 27 May 2025 06:30:00 GMT

A proven track record in global clinical leadership

QbD Group awarded Gold Label as Best Managed Company 2025

QbD Group — Fri, 23 May 2025 08:46:46 GMT

We’re proud to share that QbD Group has once again been recognized as one of Belgium’s Best Managed Companies, earning the Gold Label for the second consecutive year. This marks the sixth year in a row we’ve received this recognition – a strong confirmation of our consistent performance and long-term vision.

The Best Managed Companies programme, organized by Deloitte Private in collaboration with Econopolis and KU Leuven, evaluates Belgian privately-owned companies on strategic clarity, operational excellence, talent management, and financial results. Gold status is reserved for organizations that consistently stand out across all of these pillars over multiple years.

Welcoming Dr. Angeles Escarti-Nebot as new Division Head Regulatory Affairs | QbD Group

QbD Group — Tue, 06 May 2025 06:00:00 GMT

Navigating complexity with purpose and clarity

Azierta fully integrated into QbD Group | QbD Group

QbD Group — Mon, 10 Feb 2025 13:47:34 GMT

QbD Group unveils new brand identity | QbD Group

QbD Group — Mon, 10 Feb 2025 08:29:38 GMT

QbD Group strengthens global leadership with the appointment of Almudena del Castillo as Division Head of Vigilance & Country Manager for Spain | QbD Group

QbD Group — Mon, 03 Feb 2025 00:00:00 GMT

QbD Group announces acquisition of SciencePharma, strengthening global regulatory and quality expertise

QbD Group — Wed, 04 Dec 2024 07:45:00 GMT

Antwerp, Belgium / Warsaw, Poland – December 4, 2024 - QbD Group and SciencePharma have reached an agreement for QbD Group to acquire SciencePharma. The deal is expected to close by early 2025, pending antitrust clearance.

QbD Group, a privately held company offering comprehensive support to life sciences organizations, today announced the acquisition of SciencePharma. This strategic acquisition marks a significant milestone for QbD Group as it expands its international footprint, particularly in Poland and China. SciencePharma, known for its expertise in regulatory affairs and scientific consultancy will, as of January 2025, be part of QbD Group’s growing global network, enhancing both companies' ability to offer comprehensive solutions across the life sciences industry.